Business
Novavax to Participate in the Cantor Global Healthcare Conference
GAITHERSBURG, Md., Sept. 3, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor
About this update from Novavax, Inc.
GAITHERSBURG, Md. , Sept. 3, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the following upcoming investor conference: Cantor Global Healthcare Conference : Fireside Chat Date: Thursday, September 4, 2025 Time: 10:20 a.m. ET Location: New York, NY A webcast of the fireside chat will be available on the Events & Presentations page of the Company's website at ir.novavax.com. A replay of the webcast will be available for 30 days. About Novavax Novavax, Inc. (Nasdaq: NVAX) tackles some of the world's most pressing health challenges with its scientific expertise in vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M adjuvant. The Company's growth strategy seeks to optimize its existing partnerships and expand access to its proven technology platform via R&D innovation, organic portfolio expansion in infectious disease and beyond, and forging new partnerships and collaborations with other companies. Please visit novavax.com and LinkedIn for more information. Contacts: Investors Luis Sanay , CFA240-268-2022 [email protected] Media Giovanna Chandler 844-264-8571 [email protected] View original content to download multimedia: https://www.prnewswire.com/news-releases/novavax-to-participate-in-the-cantor-global-healthcare-conference-302544402.html SOURCE Novavax, Inc.